https://www.worldpharmatoday.com/news/exelixis-announces-acceptance-of-new-drug-application-for-cobimetinib-in-combination-with-vemurafenib-for-treatment-of-patients-with-braf-v600-mutation-positive-advanced-melanoma/ Magazine for the C-level Pharma Executives Wed, 18 Feb 2015 18:30:00 +0000 hourly 1 https://wordpress.org/?v=6.9.4